McKesson Corporation
Prezzo: 784.05Società e modello di business
McKesson Corporation is a leading healthcare services and information technology company. It primarily operates in the distribution of pharmaceuticals and provides healthcare management solutions. Major business segments include pharmaceutical distribution, medical-surgical distribution, and healthcare technology. The company's main revenue sources are from the sale of prescription drugs, medical supplies, and related services to healthcare providers, pharmacies, and hospitals.
Profilo di investimento
The investment profile of McKesson Corporation is more aligned with value investors, given its stable revenue growth and modest dividend yield. The stock may appeal to those seeking a balanced approach, as it offers potential for capital appreciation alongside income generation. However, the higher risk factors suggest caution for investors.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 38.64 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- -9.3% ↓
- Sorpresa EPS
- 1.9% in linea
- Volatilità 20g
- 1.4% stabile
- Rendimento dividendo
- 0.4% basso ultima data ex-dividendo: 2026-06-01
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-09 02:45 | Compra | Vendi | Weak fundamentals and negative momentum raise concerns. |
| 2026-06-05 02:42 | Mantieni | Compra | Mixed performance; cautious outlook amid market pressures. |
| 2026-06-01 02:44 | Vendi | Mantieni | Weak momentum and high risk overshadow potential upside. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-05-08 14:52 | UBS | Target alzato | 1000 → 1050 | 744.46 |
| 2026-05-08 12:53 | Deutsche Bank | Target abbassato | 973 → 875 | 763.9 |
| 2026-03-05 15:28 | Raymond James | Aggiorna | — → 970 | 930.31 |
Ancora nulla